This session will describe a novel pharmacotherapy mechanism of treating stimulant use disorder. The attendees will be able to explain the necessity for the dual mechanism of action in the drugs ability to attenuate rodents from self-administering cocaine. This session will also demonstrate the success of this concept, the challenges that are still ahead with drug development, and the potential for this treatment to be game changing as an aid in the treatment of stimulant use disorders.
Learning Objectives:
Learners will be able to:
Explain the novel approach to the development of these compounds in the pre-clinical setting as promising drug candidates for future clinical trials and eventual treatment tools in combating stimulant use disorders.
